Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer.
Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer.
Acta Oncol. 2016 Sep 1;:1-6
Authors: Anscher MS, Chang MG, Moghanaki D, Rosu M, Mikkelsen RB, Holdford D, Skinner V, Grob BM, Sanyal A, Wang A, Mukhopadhyay ND
PMID: 27582017 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Anscher MS, Chang MG, Moghanaki D, Rosu M, Mikkelsen RB, Holdford D, Skinner V, Grob BM, Sanyal A, Wang A, Mukhopadhyay ND Tags: Acta Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Erectile Dysfunction | Lovastatin | Prostate Cancer | Radiation Therapy